Previous 10 | Next 10 |
2024-01-05 05:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-15 15:54:00 ET Summary The healthcare sector valuation is close to 11-year averages. Pharmaceuticals/biotechnology and life science tools are close to the historical baseline, while healthcare equipment is the less attractive subsector. iShares Global Healthcare ETF is...
Haemonetics Corporation Completes Acquisition of OpSens Inc. PR Newswire BOSTON , Dec. 12, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better p...
2023-12-08 07:51:12 ET More on Opsens Opsens GAAP EPS of -C$0.01, revenue of C$14.11M Haemonetics to acquire OpSens in an all-cash deal Historical earnings data for Opsens Financial information for Opsens For further details see: OpSens receives f...
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire BOSTON , Dec. 7, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at the 42 nd Annual J.P. Morgan...
2023-11-27 10:20:05 ET More on iShares Russell 2000 ETF The Week On Wall Street: Holiday Edition IWM: Why The Small Cap Bounce May Continue RSP Versus IWM: Do We Even Need Small Caps Anymore? Maybe Not. Tech reigns in smaller caps too - Top small-cap tech sto...
2023-11-22 06:15:07 ET Summary Haemonetics has seen signs of growth and operational momentum after a challenging period during the pandemic. The company's fiscal year 2024 first half results were solid, increasing its appeal. Still trading at a small premium based on adjusted ...
2023-11-16 07:37:44 ET More on ADMA Biologics ADMA Biologics: Achieving Important Inflection Points ADMA Biologics, Inc. (ADMA) Q3 2023 Earnings Call Transcript ADMA Biologics: From Plasma To Profits With A Pinch Of Prudence ADMA Biologics Q3 2023 Earnings Pr...
2023-11-03 18:21:04 ET Haemonetics Corporation (HAE) Q2 2024 Earnings Conference Call November 02, 2023 8:00 AM ET Company Participants Olga Guyette – Senior Director, Investor Relations and Treasury Chris Simon – Chief Executive Officer Stewart Str...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
News, Short Squeeze, Breakout and More Instantly...
Haemonetics Corporation Company Name:
HAE Stock Symbol:
NYSE Market:
Haemonetics Corporation Website:
2024-07-08 21:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 PR Newswire BOSTON , July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financia...
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device PR Newswire BOSTON , June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions ...